Sample sizes for single-stage phase II clinical trials in the literature are often based on exact (binomial) tests with levels of significance (alpha (α) <5% and power >80%). This is because there is ...
The normal approximation to the binomial test with and without a continuity correction is evaluated in terms of control of Type I errors and power. The normal approximations are evaluated as robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback